WuXi AppTec在CRDMO获得2025年Frost & Sullivan全球年度公司第9年奖。 WuXi AppTec wins Frost & Sullivan’s 2025 Global Company of the Year award in CRDMO for ninth year.

WuXi Apptec连续第九年在CRDMO工业中被命名为Frost & Sullivan 2025年全球国际年公司, WuXi AppTec has been named Frost & Sullivan’s 2025 Global Company of the Year in the CRDMO industry for the ninth straight year, recognizing its end-to-end drug development services, scientific expertise, and investments in emerging therapies like complex peptides and oligonucleotides. 该奖项凸显了该公司在加速亚洲、欧洲和北美全球保健创新方面的作用。 The award highlights the company’s role in accelerating global healthcare innovation across Asia, Europe, and North America.